AlphaYouMM
Congress trade
Sen. Markwayne Mullin (R-OK) sold $1K-$15K of Abbott Laboratories (ABT) stock
Markwayne Mullin, U.S. Senator (R-OK), disclosed a sale of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Jan 31, 2025.
The trade happened on Jan 8, 2025, 23 days before it was made public.
ABT has moved -14.7% since the trade date, from $114.25 to $97.50 (Oct 2, 2026 close).
- Traded
- Jan 8, 2025
- Disclosed
- Jan 31, 2025
- Filing delay
- 23 days
- Price since
- -14.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (22)
- BuyAIT$15K-$50KJan 31, 2025
- BuyAIT$15K-$50KJan 31, 2025
- BuyCOHR$15K-$50KJan 31, 2025
- BuyCOHR$15K-$50KJan 31, 2025
- BuyCRDO$15K-$50KJan 31, 2025
- BuyCRDO$15K-$50KJan 31, 2025
- BuyDELL$15K-$50KJan 31, 2025
- BuyDELL$15K-$50KJan 31, 2025
- SellEZU$15K-$50KJan 31, 2025
- BuyGS$15K-$50KJan 31, 2025
- BuyGS$15K-$50KJan 31, 2025
- SellIEFA$15K-$50KJan 31, 2025
- BuyIRM$15K-$50KJan 31, 2025
- BuyIRM$15K-$50KJan 31, 2025
- BuyLRN$15K-$50KJan 31, 2025
- BuyLRN$15K-$50KJan 31, 2025
- BuyMTZ$15K-$50KJan 31, 2025
- BuyMTZ$15K-$50KJan 31, 2025
- BuyPRMB$15K-$50KJan 31, 2025
- BuyPRMB$15K-$50KJan 31, 2025
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.